Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 20Polycystic Ovary Syndrome 6Infertility 4Neoplasm Metastasis 2Leiomyoma 2is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 1Patient Acceptance of Health Care 1Ovarian Cysts 1Myofibroma 1Locally Advanced Breast Cancer 1Infertility, Female 1Carcinoma, Ductal 1Breast Neoplasm Malignant Female 1Breast Carcinoma In Situ 1Anovulation 1Abortion, Spontaneous 1

Interventions

Neoadjuvant Therapy 1Letrozole 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Locally Advanced Breast Cancer × Letrozole × Clear all
NCT05809024 2023-04-12

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Shandong Cancer Hospital and Institute

Phase 4 Unknown
100 enrolled
Breast

Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡